Virtus LifeSci Biotech Clinical Trials ETF
13 hedge funds and large institutions have $5.39M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$498K | |
| 2 | +$264K | |
| 3 | +$258K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$165K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$79.1K |
Top Sellers
| 1 | -$291K | |
| 2 | -$107K | |
| 3 | -$14.8K | |
| 4 |
MFS
MSI Financial Services
Springfield,
Massachusetts
|
-$6.36K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |